Movano Inc.: insider trades · United States · SEC (Form 4)

About Movano Inc.

Movano Inc. (ticker: MOVE) is a technology-enabled health company based in the United States and listed on the Nasdaq market. The company was incorporated in Delaware in January 2018 under the name Maestro Sensors Inc. and later changed its name to Movano Inc. in August 2018. Its principal executive offices are in Pleasanton, California. Movano positions itself as a developer of purpose-driven healthcare solutions aimed at bringing medical-grade data into consumer health devices. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1734750/000121390026015611/ea0276612-s1a1_movano.htm?utm_source=openai)) At a business-model level, Movano’s core proposition is built around a platform for wearable health sensing and actionable health insights. The company has described its solution set as delivering key health metrics such as heart rate, heart rate variability, sleep, respiration rate, temperature, blood oxygen saturation, steps, and calories, and it has also referenced glucose and blood-pressure data in its broader technology roadmap. Its flagship commercial product has been the Evie Ring, a smart ring designed specifically for women and launched in November 2023. Earlier disclosures show that Movano originally emphasized RF-based sensor technology and a non-invasive wearable architecture, which remains central to its brand narrative. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1734750/000121390021006218/ea134117-s1_movanoinc.htm?utm_source=openai)) In competitive terms, Movano operates in a crowded and highly capital-intensive segment spanning digital health, wearable devices, and consumer biosensing. Its differentiation has centered on a health-first positioning, a design language focused on accessibility and comfort, and a target audience that includes women—an angle the company has highlighted repeatedly. However, as a smaller-cap company, Movano faces the usual challenges of commercialization, regulatory execution, product adoption, and capital access, which make its competitive profile more fragile than that of larger wearable incumbents. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001734750/000121390026013723/ea0275899-s1a1_movano.htm?utm_source=openai)) Geographically, Movano’s operating base is concentrated in California, while the company also established Movano Ireland Limited in 2021, indicating a limited international footprint. In practical terms, the business remains centered on the United States, both from an operating and market-listing standpoint, given its Nasdaq quotation. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1734750/000121390025110877/ea0261389-10q_movano.htm?utm_source=openai)) Recent developments are important for investors. In 2025, Movano disclosed that its board was exploring strategic alternatives, including a sale or merger, and the company also received Nasdaq deficiency notices related to delayed periodic filings and bid-price compliance. Subsequently, on March 19, 2026, Movano acquired Corvex, Inc. in an all-stock transaction; the company stated that the transaction helped it satisfy Nasdaq stockholders’ equity requirements for continued listing. This sequence suggests a business in transition, with the historical wearable-health thesis now overlaid by a material corporate restructuring. ([nasdaq.com](https://www.nasdaq.com/press-release/movano-healths-board-directors-initiates-process-maximize-shareholder-value-2025-05?utm_source=openai))